The trajectory of Viagra, originally marketed by copyright, presents a intricate case study for stakeholders considering the pharmaceutical landscape . While its groundbreaking success and creation of billions in sales, the patent end has opened the door for generic medications, significantly diminishing earnings opportunities. This transition rais